Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus. 1994

K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
Department of Pediatrics, Hokkaido Children's Hospital and Medical Center, Japan.

The pharmacokinetics of mefenamic acid (MA), 2 mg/kg, were studied in 17 preterm infants with symptomatic patent ductus arteriosus. They were given this dosage orally at 24 h intervals. There were marked inter-individual differences in some of the pharmacokinetic parameters after the first dose; peak plasma concentration (Cmax) varied from 1.2 to 6.1 micrograms/mL with a mean of 3.8 micrograms/mL, time to reach Cmax (tmax) varied from 2 to 18 h with a mean of 7.7 h and plasma half-life (t1/2) varied from 3.8 to 43.6 h with a mean of 18.7 h. The group of infants (10/17) who had ductus closure after the first dose had significantly lower clearance (P < 0.01), longer t1/2 (P < 0.01) and higher 24 h plasma concentration (P < 0.001) compared to the group of infants (7/17) who had no ductus closure after the first dose. It appeared that the plasma concentration of MA had to be above 2.0 micrograms/mL and maintained at this concentration for at least 12 h for MA associated with ductus closure in preterm infants to take effect. In view of the inter-individual variation of plasma MA concentration and the effective plasma concentration, we suggest that measurement of the plasma concentration should be done 24 h after the first dose. This might be useful for safe and effective therapy for infants with ductus closure failure after the first dose.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D008528 Mefenamic Acid A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase. Apo-Mefenamic,Contraflam,Coslan,Dysman,Mefac,Mefacit,Mefenaminic Acid,Mefic,Nu-Mefenamic,PMS-Mefenamic Acid,Parkemed,Pinalgesic,Ponalar,Ponalgic,Ponmel,Ponstan,Ponstan Forte,Ponstel,Ponsyl,Pontal,Acid, Mefenamic,Apo Mefenamic,Nu Mefenamic,PMS Mefenamic Acid
D004374 Ductus Arteriosus, Patent A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth. Patent Ductus Arteriosus Familial,Patency of the Ductus Arteriosus,Patent Ductus Arteriosus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
October 2001, Clinical pharmacology and therapeutics,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
August 1980, The Medical journal of Australia,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
January 2016, Pediatrics,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
October 2012, Pediatrics and neonatology,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
April 2011, Indian pediatrics,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
October 1980, The Medical journal of Australia,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
August 1991, East African medical journal,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
January 2012, Archives of disease in childhood. Fetal and neonatal edition,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
March 2012, Archives of disease in childhood. Fetal and neonatal edition,
K Ito, and Y Niida, and J Sato, and E Owada, and K Ito, and M Umetsu
October 2001, Pharmacy world & science : PWS,
Copied contents to your clipboard!